Total imported malaria from 9 countries stratified by US and Non US reporting countries 2000–2005

<p><b>Copyright information:</b></p><p>Taken from "The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?"</p><p>http://www.malariajournal.com/content/6/1/114</p><p>Malaria Journal 2007;6():114-114.</p><p>Published online 23 Aug 2007</p><p>PMCID:PMC2020466.</p><p></p

Assuming a downwards time trend for an infection having symptoms in the same years (a) and for an infection where symptoms occur only after 10 years (b). Note:

<p>Blue rectangles represent the number of infections in the year of infection (exposure to an infection). Green “cans” represent the number of cases with symptoms; where these symptomatic cases occur in the same year as the infection (a.) or a few years later (b.) as indicated by the dashed arrow. The long-term average (e.g. 10-year average) is highlighted by a light blue oval for incidence, and by a light green oval for prevalence. The short-term average (e.g. 3-year average) is represented by a dark blue oval for incidence and purple oval for prevalence.</p

The undiscounted average burden of <i>Campylobacter</i> spp.

<p>(a) and <i>Salmonella</i> spp. (b) in the Netherlands (average of 2005–2007) in DALY per year, subdivided in YLL and YLD for acute illness, sequelae and total. The 95% uncertainty range is shown using error bars.</p

The undiscounted average burden of <i>Campylobacter</i> spp. and <i>Salmonella</i> spp.

<p>in the Netherlands (average of 2005–2007) in DALY per year, for base case and scenario analysis. DALY are subdivided in YLL and YLD for actue illness, sequelae and total. The 95% uncertainty range is shown using error bars. <b>Note:</b> “Base case” represents a situation where only severe GE cases are at risk to develop reactive arthritis (ReA). “SA: ReA” represents the scenario analysis where all GE cases are at risk to develop ReA.</p